Claus Bachert

Claus Bachert

Universiteit Gent

H-index: 146

Europe-Belgium

About Claus Bachert

Claus Bachert, With an exceptional h-index of 146 and a recent h-index of 102 (since 2020), a distinguished researcher at Universiteit Gent,

His recent articles reflect a diverse array of research interests and contributions to the field:

Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract: a long-term comparative study

Evaluation of ongoing mepolizumab treatment in chronic rhinosinusitis with nasal polyps

Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?

Endoskopisches Scoring von Nasenpolypen: Executive Summary des EAACI-Positionspapiers

Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: a systematic review of the current knowledge towards an attempt to compare …

Impact of Mepolizumab on Sleep Disturbance in Patients With Chronic Rhinosinusitis With Nasal Polyps and/or Asthma: Analysis From SYNAPSE and MUSCA

Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma

MZB1-expressing cells are essential for local immunoglobulin production in chronic rhinosinusitis with nasal polyps

Claus Bachert Information

University

Universiteit Gent

Position

Buitengewoon hoogleraar

Citations(all)

100140

Citations(since 2020)

46158

Cited By

71033

hIndex(all)

146

hIndex(since 2020)

102

i10Index(all)

645

i10Index(since 2020)

511

Email

University Profile Page

Universiteit Gent

Top articles of Claus Bachert

Title

Journal

Author(s)

Publication Date

Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract: a long-term comparative study

European Archives of Oto-Rhino-Laryngology

Tijl Vermassen

Stijn De Keukeleire

Michael Saerens

Sylvester Heerwegh

Jens M Debacker

...

2024/1/16

Evaluation of ongoing mepolizumab treatment in chronic rhinosinusitis with nasal polyps

Ludger Klimek

Ulrike Förster-Ruhrmann

Heidi Olze

Achim G Beule

Adam M Chaker

...

2024/2/22

Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?

Ludger Klimek

Ulrike Förster-Ruhrmann

Heidi Olze

Achim G Beule

Adam M Chaker

...

2024

Endoskopisches Scoring von Nasenpolypen: Executive Summary des EAACI-Positionspapiers

HNO Nachrichten

Ludger Klimek

Philippe Gevaert

Claus Bachert

Ralph Mösges

Martin Wagenmann

...

2024/2

Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: a systematic review of the current knowledge towards an attempt to compare …

Georgios X Papacharalampous

Jannis Constantinidis

George Fotiadis

Nan Zhang

Claus Bachert

...

2024/1

Impact of Mepolizumab on Sleep Disturbance in Patients With Chronic Rhinosinusitis With Nasal Polyps and/or Asthma: Analysis From SYNAPSE and MUSCA

Journal of Allergy and Clinical Immunology

Peter Howarth

Joaquim Mullol

Claus Bachert

Wytske Fokkens

Steven Smith

...

2024/2/1

Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma

Journal of Asthma and Allergy

Mark Gurnell

Amr Radwan

Claus Bachert

Njira Lugogo

Seong H Cho

...

2024/12/31

MZB1-expressing cells are essential for local immunoglobulin production in chronic rhinosinusitis with nasal polyps

Annals of Allergy, Asthma & Immunology

Yanran Huang

Zhaofeng Xu

Gabriele Holtappels

Yang Shen

Thibaut Van Zele

...

2024/2/1

Reviews and feature articles

Tuomas Jartti

James E Gern

Michael R Edwards

Katherine Strong

Aoife Cameron

...

2017

Associations of tenascin C with Th2 response, edema degree, and disease severity in patients with chronic rhinosinusitis with nasal polyps

Allergy

Min Wang

Haiyang Meng

Nan Zhang

Jian Jiao

Yifei Wang

...

2024/1/17

Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and …

International forum of allergy & rhinology

Claus Bachert

Asif H Khan

Stella E Lee

Claire Hopkins

Anju T Peters

...

2024/3

Staphylococcal enterotoxin-specific IgE sensitization: a potential predictor of fixed airflow obstruction in elderly asthma

Allergy, Asthma & Immunology Research

Ha-Kyeong Won

Woo-Jung Song

Sung Do Moon

Kyoung-Hee Sohn

Ju-Young Kim

...

2023/3

The unified airway hypothesis: evidence from specific intervention with anti-interleukin-5 biologic therapy

Claus Bachert

Amber U Luong

Philippe Gevaert

Joaquim Mullol

Steven G Smith

...

2023/5/18

Impact de mépolizumab sur le sommeil chez les patients avec polypose nasosinusienne (PNS): les données de l’étude SYNAPSE

Revue des Maladies Respiratoires Actualités

J Mullol

C Bachert

W Fokkens

SG Smith

T Keeley

...

2023/1/1

Respiratory virome profiles reflect antiviral immune responses

Allergy

Judit Rovira Rubió

Spyridon Megremis

Maria Pasioti

John Lakoumentas

Bede Constantinides

...

2023/5

Eosinophils and tissue remodeling: relevance to airway disease

Salman Siddiqui

Claus Bachert

Leif Bjermer

Kathleen M Buchheit

Mario Castro

...

2023/6/19

Neutrophilic inflammation in chronic rhinosinusitis

Tim Delemarre

Claus Bachert

2023/2/1

Innovative treatments for severe uncontrolled chronic rhinosinusitis with nasal polyps

Yanran Huang

Nan Zhang

Claus Bachert

2023/8/3

Type 2 chronic inflammatory diseases: targets, therapies and unmet needs

Pavel Kolkhir

Cezmi A Akdis

Mübeccel Akdis

Claus Bachert

Thomas Bieber

...

2023/9

Effect of Dupilumab on type 2 biomarkers in chronic rhinosinusitis with nasal polyps: SINUS-52 study results

Annals of Otology, Rhinology & Laryngology

Claus Bachert

Tanya M Laidlaw

Seong H Cho

Joaquim Mullol

Brian N Swanson

...

2023/12

See List of Professors in Claus Bachert University(Universiteit Gent)

Claus Bachert FAQs

What is Claus Bachert's h-index at Universiteit Gent?

The h-index of Claus Bachert has been 102 since 2020 and 146 in total.

What are Claus Bachert's top articles?

The articles with the titles of

Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract: a long-term comparative study

Evaluation of ongoing mepolizumab treatment in chronic rhinosinusitis with nasal polyps

Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?

Endoskopisches Scoring von Nasenpolypen: Executive Summary des EAACI-Positionspapiers

Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: a systematic review of the current knowledge towards an attempt to compare …

Impact of Mepolizumab on Sleep Disturbance in Patients With Chronic Rhinosinusitis With Nasal Polyps and/or Asthma: Analysis From SYNAPSE and MUSCA

Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma

MZB1-expressing cells are essential for local immunoglobulin production in chronic rhinosinusitis with nasal polyps

...

are the top articles of Claus Bachert at Universiteit Gent.

What is Claus Bachert's total number of citations?

Claus Bachert has 100,140 citations in total.